Cargando…

Systematic review and network meta-analysis of the efficacy of existing treatments for patients with recurrent glioblastoma

BACKGROUND: Despite advances in the treatment of cancers over the last years, treatment options for patients with recurrent glioblastoma (rGBM) remain limited with poor outcomes. Many regimens have been investigated in clinical trials; however, there is a lack of knowledge on comparative effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schritz, Anna, Aouali, Nassera, Fischer, Aurélie, Dessenne, Coralie, Adams, Roisin, Berchem, Guy, Huiart, Laetitia, Schmitz, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174573/ https://www.ncbi.nlm.nih.gov/pubmed/34095835 http://dx.doi.org/10.1093/noajnl/vdab052

Ejemplares similares

Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells
por: Aouali, Nassera, et al.
Publicado: (2015)

Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
por: Goetzinger, Catherine, et al.
Publicado: (2022)

The Use of Social Media for Health Research Purposes: Scoping Review
por: Bour, Charline, et al.
Publicado: (2021)

Scoping review protocol on the use of social media for health research purposes
por: Bour, Charline, et al.
Publicado: (2021)

Inhibition of HIF1α-Dependent Upregulation of Phospho-l-Plastin Resensitizes Multiple Myeloma Cells to Frontline Therapy
por: Bosseler, Manon, et al.
Publicado: (2018)

Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
por: Moussay, Etienne, et al.
Publicado: (2010)

Methods to Generate Innovative Research Ideas and Improve Patient and Public Involvement in Modern Epidemiological Research: Review, Patient Viewpoint, and Guidelines for Implementation of a Digital Cohort Study
por: Aguayo, Gloria A, et al.
Publicado: (2021)

Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study
por: Fagherazzi, Guy, et al.
Publicado: (2021)

The use of continuous data versus binary data in MTC models: A case study in rheumatoid arthritis
por: Schmitz, Susanne, et al.
Publicado: (2012)

Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
por: Lin, Hao, et al.
Publicado: (2023)

The challenges of implementing advanced access for residents in family medicine in Quebec. Do promising strategies exist?
por: Abou Malham, Sabina, et al.
Publicado: (2018)

Prevalence and Cost of Care for Parkinson’s Disease in Luxembourg: An Analysis of National Healthcare Insurance Data
por: Schmitz, Susanne, et al.
Publicado: (2022)

Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials
por: Bertolotti, Antoine, et al.
Publicado: (2020)

Digital Health Strategies to Fight COVID-19 Worldwide: Challenges, Recommendations, and a Call for Papers
por: Fagherazzi, Guy, et al.
Publicado: (2020)

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma
por: Kumar, Gunjesh, et al.
Publicado: (2021)

Unraveling the concepts of distress, burnout, and depression in type 1 diabetes: A scoping review
por: Kiriella, Dona A., et al.
Publicado: (2021)

Author Correction: Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
por: Ruiz‑Castell, Maria, et al.
Publicado: (2021)

Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study
por: Ruiz-Castell, Maria, et al.
Publicado: (2021)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
por: Reithmeier, Thomas, et al.
Publicado: (2010)

Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma
por: Narita, Yoshitaka, et al.
Publicado: (2022)

Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study
por: Fagherazzi, Guy, et al.
Publicado: (2020)

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway
por: Tabouret, Emeline, et al.
Publicado: (2015)

Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma
por: Spiegl-Kreinecker, S, et al.
Publicado: (2007)

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
por: Santoni, Matteo, et al.
Publicado: (2013)

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
por: Wong, E T, et al.
Publicado: (2015)

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
por: Wong, E T, et al.
Publicado: (2015)

Bevacizumab in recurrent glioblastoma
por: Martinez, Nina L., et al.
Publicado: (2019)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer
por: El-Khoury, Victoria, et al.
Publicado: (2018)

Safety and efficacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma
por: Ko, Andrew L., et al.
Publicado: (2012)

Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'
por: Ellsworth, Susannah, et al.
Publicado: (2015)

A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
por: Lassman, Andrew B., et al.
Publicado: (2022)

Therapeutic Options for Recurrent Glioblastoma—Efficacy of Talaporfin Sodium Mediated Photodynamic Therapy
por: Kobayashi, Tatsuya, et al.
Publicado: (2022)

Investigating unmet need for healthcare using the European Health Interview Survey: a cross-sectional survey study of Luxembourg
por: Moran, Valerie, et al.
Publicado: (2021)

Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
por: Mehta, Amol, et al.
Publicado: (2018)

Bevacizumab for the Treatment of Recurrent Glioblastoma
por: Chamberlain, Marc C.
Publicado: (2011)

New therapies for recurrent glioblastomas
por: Wen, Patrick Y
Publicado: (2009)

Recurrent Glioblastoma: Nuances and Insights
por: Alimohamadi, Maysam, et al.
Publicado: (2021)

Recurrent Glioblastoma: What Is the Route?
por: Bosio, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g8j347pbm58u8j7q1go0t1fecs